These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 6290911

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [IgG and IgA antibodies to the Epstein-Barr virus and nasopharyngeal carcinoma].
    Vera Sempere FJ.
    Med Clin (Barc); 1992 May 16; 98(19):758-9. PubMed ID: 1318986
    [No Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus antibodies in Sudanese patients with nasopharyngeal carcinoma: a preliminary report.
    Malik MO, Banatvala J, Hutt MS, Abu-Sin AY, Hidaytallah A, El-Hadi AE.
    J Natl Cancer Inst; 1979 Feb 16; 62(2):221-4. PubMed ID: 216831
    [Abstract] [Full Text] [Related]

  • 6. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH, Pearson GR, Armstrong M, Bengali Z, Berenberg J, Easton J, Goepfert H, Henle G, Henle W, Heffner D, Huang A, Hyams VJ, Lanier A, Neel HB, Pilch B, Pointek N, Taylor W, Terebelo H, Weiland L.
    Cancer Detect Prev; 1981 Feb 16; 4(1-4):307-12. PubMed ID: 6299561
    [Abstract] [Full Text] [Related]

  • 7. A prospective study of antibodies to Epstein-Barr virus DNase and viral capsid antigen for prognostication of patients with nasopharyngeal carcinoma.
    Hsu MM, Chen JY, Chen CJ.
    Taiwan Yi Xue Hui Za Zhi; 1988 Oct 16; 87(10):984-8. PubMed ID: 2853721
    [No Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
    Henle W, Henle G, Ho JH.
    IARC Sci Publ (1971); 1978 Oct 16; (20):427-37. PubMed ID: 215525
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nasopharyngeal carcinoma and Epstein-Barr virus. II. Clinical course and the anti-VCA antibody.
    Lynn T, Tu S, Hirayama T, Kawamura A.
    Jpn J Exp Med; 1973 Apr 16; 43(2):135-44. PubMed ID: 4352112
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
    Pearson G, Dewey F, Klein G, Henle G, Henle W.
    J Natl Cancer Inst; 1970 Nov 16; 45(5):989-95. PubMed ID: 18605425
    [Abstract] [Full Text] [Related]

  • 13. Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups.
    Neel HB, Pearson GR, Taylor WF.
    Ann Otol Rhinol Laryngol; 1984 Nov 16; 93(5 Pt 1):477-82. PubMed ID: 6093669
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nasopharyngeal carcinoma and Epstein-Barr virus. I. Factors related to the anti-VCA antibody.
    Lynn T, Tu S, Hirayama T, Kawamura A.
    Jpn J Exp Med; 1973 Apr 16; 43(2):121-33. PubMed ID: 4352111
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.